CVRx, Inc. (CVRX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CVRX
- Company CVRx, Inc.
- Price $2.39
- Changes Percentage -59.76
- Change -3.55
- Day Low $2.3
- Day High $3.07
- Year High $11.3
- Year Low $4.37
- Market Cap $132,812,400
- Price Avg 50 EMA (D) $5.37
- Price Avg 200 EMA (D) $7.41
- Exchange NASDAQ
- Volume 65,361
- Average Volume 318,767
- Open $3.01
- Previous Close $5.94
- EPS -2.02
- PE -2.48
- Earnings Announcement 2026-08-06 20:00:00
- Shares Outstanding $26,535,944
Company brief: CVRX, INC. (CVRX )
- Healthcare
- Medical - Devices
- Mr. Kevin Hykes
- https://www.cvrx.com
- US
- N/A
- 06-30-2021
- US1266381052
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.